海内外催化不断，医疗创新ETF(516820)红盘向上

Group 1 - The core viewpoint of the news highlights the positive performance of the China Securities Pharmaceutical and Medical Device Innovation Index, which rose by 0.50% as of February 10, 2026, with notable increases in constituent stocks such as Haizhi Science (3.59%) and WuXi AppTec (2.11%) [1] - A South Korean digital health startup has developed an AI-based digital diagnostic platform aimed at helping individuals detect early signs of heart attacks at home [1] - Ping An Securities indicates that the ongoing equipment upgrade policies and the promotion of community medical systems are opening up procurement opportunities for grassroots medical devices, with leading domestic companies like Mindray Medical and United Imaging showing significant year-on-year growth in bidding amounts of 36%, 34%, and 77% respectively [1] Group 2 - As of January 30, 2026, the top ten weighted stocks in the China Securities Pharmaceutical and Medical Device Innovation Index include WuXi AppTec, Mindray Medical, and others, collectively accounting for 63.9% of the index [2] - The Medical Innovation ETF closely tracks the China Securities Pharmaceutical and Medical Device Innovation Index, which selects 30 profitable and growth-oriented companies in the pharmaceutical and medical device sectors to reflect their overall performance [1]